Early Career Advisory Panel

The Early Career Advisory Panel is made up of early career bioscientists, defined as those less than ten years from their PhD or other most recent qualification, and works to ensure that the views, needs and concerns of this community are recognised and aligned with Society activities and initiatives.

Committees and Panels Audit and Finance Committee Awards Committee Grants Committee Equity, Diversity and Inclusion (EDI) Committee Policy Advisory Panel Industry Advisory Panel People, Remuneration and Nominations Committee Publications Committee Portland Press Limited Board Policy, Education and Communities Committee Conferences and Training Panel Research Area

Early Career Advisory Panel Terms of Reference

Early Career Advisory Panel Terms Of Reference

10 members

Early Career Representative Trustee / Chair / University of Leeds

Dr Hannah Britt

Early Career Representative Trustee / Chair

University of Leeds

EDI Representative / Newcastle University

Dr Amy Vincent

EDI Representative

Newcastle University

Ordinary Member / Aston University

Dr Ben Lane

Ordinary Member

Aston University

Ordinary Member / Medical University of Lublin, Poland

Dr Ewa Blaszczak

Ordinary Member

Medical University of Lublin, Poland

Ordinary Member / University of Oxford

Dr Georgina Benn

Ordinary Member

University of Oxford

Ordinary member / EPFL, Switzerland

Dr Harry Williams

Ordinary member

EPFL, Switzerland

Dr Williams is currently a postdoctoral researcher working at the Bernhard-Nocht-Institute for Tropical Medicine (BNITM) in Hamburg, Germany. At the BNITM, his research is focussed on determining how viruses replicate in the human body. Before this, he obtained his PhD in structural biology from Keele University, UK.

Ordinary Member / University of Oxford

Dr Liu He

Ordinary Member

University of Oxford

Ordinary Member / University of Manchester

Dr Micaela Chacon

Ordinary Member

University of Manchester

Industry Representative / Charles River Laboratories

Gareth Langley

Industry Representative

Charles River Laboratories

Gareth Langley is a Research Leader at Charles River Laboratories, where he oversees a portfolio of multidisciplinary small-molecule drug discovery projects spanning diverse therapeutic areas and target classes. In addition to his scientific project leadership roles, Gareth mentors several of his junior colleagues and has extensive hands-on expertise in assay development, laboratory automation and in vitro pharmacology.

Before joining CRL, Gareth served as lead biochemist on a cross-institutional drug discovery program supported by the IMI-ENABLE initiative, a major collaboration between academic and industry partners, through hit-to-lead and early LO.

Gareth’s role is underpinned by a strong academic foundation in chemistry, biochemistry, and molecular biosciences. He graduated from the University of Oxford in 2013 with an MChem in Chemistry, completing a fourth-year project at the interface of chemistry and biochemistry. He went on to earn his DPhil at the University of Oxford under Prof. Chris Schofield, focusing on biochemistry and molecular biology in collaboration with industrial partners and funding through the EPRSC and Doctoral Training Centre.

His research has been published in high-impact journals, presented at leading international conferences, and Gareth is a named inventor on multiple patents. Passionate about inspiring future scientists, Gareth has been a STEM ambassador since his first year of undergraduate study.

Policy, Education and Communities Representative / Taipale Lab (GenGen)

Dr Connor Rogerson

Policy, Education and Communities Representative

Taipale Lab (GenGen)